Mathur, G., S. Nain, and P.K. Sharma, Cancer: an overview. Acad. J. Cancer Res, 2015. 8(1).

Tuğrak, M., et al., Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potentialanticancer agents and hCA I and II inhibitors. Turkish Journal of Chemistry, 2021. 45(3): p. 528-539.

Nemr, M.T., et al., Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. RSC advances, 2021. 11(42): p. 26241-26257.

Al Tameemi, W., et al., Hypoxia-modified cancer cell metabolism. Frontiers in cell and developmental biology, 2019. 7: p. 4.

Nguyen, P.L., et al., Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin. International Journal of Molecular Sciences, 2022. 23(17): p. 9903.

Kumar, S., et al., Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry, 2021. 209: p. 112923.

Supuran, C.T., Carbonic anhydrase inhibitors. Bioorganic & medicinal chemistry letters, 2010. 20(12): p. 3467-3474.

Angeli, A., et al., New sulfanilamide derivatives incorporating heterocyclic carboxamide moieties as carbonic anhydrase inhibitors. Pharmaceuticals, 2021. 14(8): p. 828.

Mboge, M.Y., et al., Carbonic anhydrases: role in pH control and cancer. Metabolites, 2018. 8(1): p. 19.

Sedlakova, O., et al., Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. Frontiers in physiology, 2014. 4: p. 400.

Tafreshi, N.K., et al., Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases. Carbonic anhydrase: Mechanism, regulation, links to disease, and industrial applications, 2014: p. 221-254.

Nada, H., et al., 4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 2022. 37(1): p. 994-1004.

Scozzafava, A., et al., Anticancer and antiviral sulfonamides. Current medicinal chemistry, 2003. 10(11): p. 925-953.

Supuran, C.T., A. Casini, and A. Scozzafava, Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Medicinal Research Reviews, 2003. 23(5): p. 535-558.

Abbate, F., et al., Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorganic & medicinal chemistry letters, 2004. 14(1): p. 217-223.

Cornelio, B., et al., 4-Arylbenzenesulfonamides as human carbonic anhydrase Inhibitors (hCAIs): Synthesis by Pd nanocatalyst-mediated Suzuki–Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies. Journal of medicinal chemistry, 2016. 59(2): p. 721-732.

Bonardi, A., et al., Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action. Journal of Medicinal Chemistry, 2020. 63(13): p. 7422-7444.

Li, Y., et al., Thiadiazole—A promising structure in medicinal chemistry. ChemMedChem, 2013. 8(1): p. 27-41.

Al-Mulla, A., A review: biological importance of heterocyclic compounds. Der Pharma Chemica, 2017. 9(13): p. 141-147.

Asif, M., Anti-neuropathic and anticonvulsant activities of various substituted triazoles analogues. Chem Int, 2015. 1(4): p. 174-183.

Dai, J., et al., Synthesis methods of 1, 2, 3-/1, 2, 4-triazoles: A review. Frontiers in Chemistry, 2022. 10.

Gadhave, P.P., et al., Current biological and synthetic profile of triazoles: A review. Annals Biol. Res, 2010. 1(1): p. 82-89.

Kaur, R., et al., Recent developments on 1, 2, 4-triazole nucleus in anticancer compounds: a review. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 2016. 16(4): p. 465-489.

Billah, M.M., et al., Determination of the presence and pharmacokinetic profile of ciprofloxacin by TLC and HPLC method respectively in broiler chicken after single oral administration. The Journal of Antibiotics, 2014. 67(11): p. 745-748.

Mina, S., et al., Synthesis and biological investigation of some novel sulfonamide and amide derivatives containing coumarin moieties. 2014.

Li, J. and Y. Sha, A convenient synthesis of amino acid methyl esters. Molecules, 2008. 13(5): p. 1111-1119.

Park, H.-S., et al., Synthesis and characterization of novel hydantoins as potential COX-2 inhibitors: 1, 5-Diarylhydantoins. Bulletin of the Korean Chemical Society, 2007. 28(5): p. 751-757.

Jubie, S., et al., Synthesis and biological evaluation of some schiff bases of [4-(amino)-5-phenyl-4H-1, 2, 4-triazole-3-thiol]. Pak. J. Pharm. Sci, 2011. 24(2): p. 109-112.

Husain, A., M.A. Naseer, and M. Sarafroz, Synthesis and anticonvulsant activity of some novel fused heterocyclic 1, 2, 4-triazolo-[3, 4-b]-1, 3, 4-thiadiazole derivatives. Acta Pol Pharm, 2009. 66(2): p. 135-40.

Pavia, D.L., et al., Introduction to spectroscopy. 2014: Cengage learning.